Status:
COMPLETED
Survey of Procedures and Resources for Initiating Treatment of HIV in Africa-Malawi
Lead Sponsor:
Boston University
Collaborating Sponsors:
Bill and Melinda Gates Foundation
University of Witwatersrand, South Africa
Conditions:
HIV
Antiretroviral Therapy
Eligibility:
All Genders
18+ years
Brief Summary
In its 2017 revision of the global guidelines for HIV care and treatment, the World Health Organization (WHO) called for rapid or same-day initiation of antiretroviral treatment (ART) for eligible pat...
Eligibility Criteria
Inclusion
- Adult patients (at least 18 years old)
- Tested HIV-positive (or brought proof of positive HIV status) at a study site within the study period (1 July 2018 through 30 June 2019)
Exclusion
- Pregnant
Key Trial Info
Start Date :
May 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2024
Estimated Enrollment :
1781 Patients enrolled
Trial Details
Trial ID
NCT04468399
Start Date
May 21 2020
End Date
December 1 2024
Last Update
December 27 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinton Health Access Initiative
Lilongwe, Malawi
2
Amy Huber
Johannesburg, Gauteng, South Africa, 2193